Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DuoTrav Replacement Therapy in Glaucoma/Ocular Hypertension
NCT00828906Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Feb 2009
- Primary completion
- Nov 2009
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of travoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Feb 2009; status: completed.
02
Drugs
travoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00828906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00828906.